Friedman Bart has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 8789 shares of Ovid Therapeutics Inc. ($OVID) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Not found | A | Common Stock | 8789 | $2.56 | 8,789.0000 | 71,212,353 | 9999.99% | 0.01% |
| Feb. 26, 2026 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Not found | A | Employee Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 71,212,353 | 9999.99% | 0.09% |
| Feb. 20, 2025 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Not found | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2024 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Not found | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Ovid Therapeutics Inc. | $OVID | Friedman Bart | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |